Australian Researchers to Conduct Study on Managing Meth Addiction Using Psilocybin

April 5, 2021 2:55 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Researchers from Sydney, Australia, are planning a clinical trial with the objective to discover whether administering psychedelics, specifically psilocybin, to individuals who use methamphetamines, commonly known as “meth,” could help manage their addiction. Psilocybin is the active psychedelic ingredient found in magic mushrooms.

The scientists from St. Vincent’s Hospital, Darlinghurst, will administer psychedelic therapy to patients who are dependent on ice, or meth. A St. Vincent specialist in toxicology, clinical pharmacology and addiction medicine, lead researcher Dr. Jonathan Brett stated that he was extremely aware of the pressures to carry out the trial in the strictest scientific and ethical boundaries. He also noted that people at home are encouraged to refrain from trying the approach at home, explaining&

Read More >>

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://ibn.fm/PULL

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Investor Brand Network, Press Releases